[Toxiderma induced by fosfestrol (ST52)].
Fradet
G
G
Service de Médecine Interne, Centre Hospitalier Général, Luçon.
Deniaud
C
C
Le Nechet
A
A
Charlois
T
T
D000970:Antineoplastic Agents / Q000009:adverse effects*; D004054:Diethylstilbestrol / Q000009:adverse effects / Q000031:analogs & derivatives*; D003875:Drug Eruptions / Q000209:etiology*; D006801:Humans; D008297:Male; D008875:Middle Aged
D000970:Antineoplastic Agents; D004054:Diethylstilbestrol; C004955:fosfestrol
Toxidermie imputable au fosfestrol (ST52*).